1. Home
  2. UNCY vs POCI Comparison

UNCY vs POCI Comparison

Compare UNCY & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • POCI
  • Stock Information
  • Founded
  • UNCY 2016
  • POCI 1982
  • Country
  • UNCY United States
  • POCI United States
  • Employees
  • UNCY N/A
  • POCI N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • UNCY Health Care
  • POCI Health Care
  • Exchange
  • UNCY Nasdaq
  • POCI Nasdaq
  • Market Cap
  • UNCY 31.9M
  • POCI 32.3M
  • IPO Year
  • UNCY 2021
  • POCI N/A
  • Fundamental
  • Price
  • UNCY $0.66
  • POCI $5.11
  • Analyst Decision
  • UNCY Strong Buy
  • POCI
  • Analyst Count
  • UNCY 4
  • POCI 0
  • Target Price
  • UNCY $5.50
  • POCI N/A
  • AVG Volume (30 Days)
  • UNCY 1.5M
  • POCI 11.8K
  • Earning Date
  • UNCY 11-13-2024
  • POCI 02-12-2025
  • Dividend Yield
  • UNCY N/A
  • POCI N/A
  • EPS Growth
  • UNCY N/A
  • POCI N/A
  • EPS
  • UNCY N/A
  • POCI N/A
  • Revenue
  • UNCY N/A
  • POCI $18,980,148.00
  • Revenue This Year
  • UNCY N/A
  • POCI N/A
  • Revenue Next Year
  • UNCY N/A
  • POCI N/A
  • P/E Ratio
  • UNCY N/A
  • POCI N/A
  • Revenue Growth
  • UNCY N/A
  • POCI N/A
  • 52 Week Low
  • UNCY $0.20
  • POCI $3.47
  • 52 Week High
  • UNCY $1.82
  • POCI $6.90
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 52.04
  • POCI 50.35
  • Support Level
  • UNCY $0.62
  • POCI $4.92
  • Resistance Level
  • UNCY $0.87
  • POCI $5.48
  • Average True Range (ATR)
  • UNCY 0.08
  • POCI 0.20
  • MACD
  • UNCY -0.01
  • POCI -0.02
  • Stochastic Oscillator
  • UNCY 15.45
  • POCI 28.36

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

Share on Social Networks: